These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 8106)

  • 1. Insulin and glucagon degradation by the kidney. II. Characterization of the mechanisms at neutral pH.
    Duckworth WC
    Biochim Biophys Acta; 1976 Jul; 437(2):531-42. PubMed ID: 8106
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insulin and glucagon degradation by the kidney. I. Subcellular distribution under different assay condition.
    Duckworth WC
    Biochim Biophys Acta; 1976 Jul; 437(2):518-30. PubMed ID: 8105
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulin degradation by human skeletal muscle.
    Neal GW; Kitabchi AE
    Biochim Biophys Acta; 1982 Nov; 719(2):259-66. PubMed ID: 6758860
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulin and glucagon binding and degradation by kidney cell membranes.
    Duckworth WC
    Endocrinology; 1978 Jun; 102(6):1766-74. PubMed ID: 105882
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proteolytic degradation and modification of rat prolactin by subcellular fractions of the rat ventral prostate gland.
    Compton MM; Witorsch RJ
    Endocrinology; 1984 Aug; 115(2):476-84. PubMed ID: 6378591
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [125I]-insulin metabolism by the rat liver in vivo: evidence that a neutral thiol-protease mediates rapid intracellular insulin degradation.
    Williams FG; Johnson DE; Bauer GE
    Metabolism; 1990 Mar; 39(3):231-41. PubMed ID: 2407925
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glucagon degradation by human mononuclear cells.
    Neal GW; Solomon SS; Shankar TP; Duckworth WC
    Diabetologia; 1983 Nov; 25(5):404-10. PubMed ID: 6317504
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The calcium dependence of insulin degradation by rat skeletal muscle.
    Ryan MP; Gifford JD; Solomon SS; Duckworth WC
    Endocrinology; 1985 Oct; 117(4):1693-8. PubMed ID: 3928338
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Subcellular localization and preliminary characterization of islet hormone-degrading activities in anglerfish islet tissue.
    Bauer GE; Johnson DE; Noe BD
    Gen Comp Endocrinol; 1983 Mar; 49(3):414-27. PubMed ID: 6341166
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proteolytic degradation of insulin and glucagon.
    Duckworth WC; Heinemann M; Kitabchi AE
    Biochim Biophys Acta; 1975 Feb; 377(2):421-30. PubMed ID: 235306
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin degradation. XVIII. On the regulation of glutathione-insulin transhydrogenase in the hyperglycemic obese (ob/ob) mouse.
    Varandani PT; Nafz MA
    Biochim Biophys Acta; 1976 Dec; 451(2):382-92. PubMed ID: 187226
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A rat kidney neutral peptidase that degrades B chain of insulin, glucagon, and ACTH: purification by affinity chromatography and some properties.
    Varandani PT; Shroyer LA
    Arch Biochem Biophys; 1977 May; 181(1):82-93. PubMed ID: 18115
    [No Abstract]   [Full Text] [Related]  

  • 13. Human red blood cell insulin-degrading enzyme and rat skeletal muscle insulin protease share antigenic sites and generate identical products from insulin.
    Duckworth WC; Hamel FG; Bennett R; Ryan MP; Roth RA
    J Biol Chem; 1990 Feb; 265(5):2984-7. PubMed ID: 1689296
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Metabolism of insulin and glucagon. Heterogeneity and characterization of insulin and glucagon degrading enzyme systems in cell fractions of the rat liver].
    Ansorge S; Kaiser B; Senger U; Bohley P; Langner J; Kirschke H
    Acta Biol Med Ger; 1972; 28(5):761-77. PubMed ID: 4627491
    [No Abstract]   [Full Text] [Related]  

  • 15. Characterization of insulin-degrading activity of intact and subcellular components of human fibroblasts.
    Stentz FB; Harris HL; Kitabchi AE
    Endocrinology; 1985 Mar; 116(3):926-34. PubMed ID: 3882399
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Degradation of insulin and glucagon in developing rat kidney: immunolocalization of insulin-glucagon-specific protease and quantitative estimation.
    Dorn A; Bernstein HG; Reiser M; Rinne A; Ansorge S
    J Histochem Cytochem; 1986 Mar; 34(3):411-2. PubMed ID: 3512695
    [No Abstract]   [Full Text] [Related]  

  • 17. Endosomal proteolysis of glucagon at neutral pH generates the bioactive degradation product miniglucagon-(19-29).
    Authier F; Cameron PH; Merlen C; Kouach M; Briand G
    Endocrinology; 2003 Dec; 144(12):5353-64. PubMed ID: 12959981
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insulin degradation by isolated fat cells and their subcellular fractions.
    Hammond JM; Jarett L
    Diabetes; 1975 Nov; 24(11):1011-9. PubMed ID: 241673
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Subcellular distribution of proteolytic activities degrading bioactive peptides and analogues in the rat small intestinal and colonic enterocytes.
    Bai JP
    J Pharm Pharmacol; 1994 Aug; 46(8):671-5. PubMed ID: 7815282
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fate of injected glucagon taken up by rat liver in vivo. Degradation of internalized ligand in the endosomal compartment.
    Authier F; Janicot M; Lederer F; Desbuquois B
    Biochem J; 1990 Dec; 272(3):703-12. PubMed ID: 2268296
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.